⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GLSI News
Greenwich LifeSciences, Inc.
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
globenewswire.com
GLSI
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
globenewswire.com
GLSI
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
globenewswire.com
GLSI
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
globenewswire.com
GLSI
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
globenewswire.com
GLSI
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
globenewswire.com
GLSI
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
globenewswire.com
GLSI
Greenwich LifeSciences Provides Update on Financing Strategy
globenewswire.com
GLSI
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
globenewswire.com
GLSI
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
globenewswire.com
GLSI